Clinical Studies

Capnia has completed two randomized, placebo-controlled Phase II trials treating over 400 patients  in 21 US and Canadian clinical centers.  We are currently planning our pivotal Phase III trials.

Please check back for a list of clinical centers and information regarding participation in one of our migraine treatment protocols.